NCT04400266View on ClinicalTrials.gov

Buspirone and Melatonin for Depression Following Traumatic Brain Injury

PHASE4RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
DepressionBrain Injuries, Traumatic
Interventions
DRUG

Buspirone

Buspirone 15mg once daily

DRUG

Mealatonin

Melatonin 3mg once nightly

Trial Locations (2)

02144

RECRUITING

Massachusetts General Hospital, Boston

02129

RECRUITING

Massachusetts General Hospital Home Base Program, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER